Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Clinical relevance of increased retinoid and cAMP transcriptional programs in tumor cells rendered non-malignant by dominant negative inhibition of NFkappaB.

Andela VB, Gingold BI, Souza MD, O'Keefe RJ, Puzas EJ, Schwarz EM, Rosier RN.

Cancer Lett. 2003 May 8;194(1):37-43. Erratum in: Cancer Lett. 2004 Feb 10;204(1):117.

PMID:
12706857
2.

Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.

Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Dec 3;279(49):51630-46. Epub 2004 Sep 7.

3.

Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB.

Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ, Rosier RN.

Cancer Res. 2000 Dec 1;60(23):6557-62.

4.

Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.

Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB.

Mol Cancer Ther. 2004 Mar;3(3):309-16.

5.

Combination of an SRC kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness.

Boyd DD, Wang H, Avila H, Parikh NU, Kessler H, Magdolen V, Gallick GE.

Clin Cancer Res. 2004 Feb 15;10(4):1545-55.

7.

Tumor necrosis factor-alpha activates NFkappaB to inhibit renin transcription by targeting cAMP-responsive element.

Todorov VT, Völkl S, Müller M, Bohla A, Klar J, Kunz-Schughart LA, Hehlgans T, Kurtz A.

J Biol Chem. 2004 Jan 9;279(2):1458-67. Epub 2003 Oct 16.

8.

T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter.

Marwaha V, Chen YH, Helms E, Arad S, Inoue H, Bord E, Kishore R, Sarkissian RD, Gilchrest BA, Goukassian DA.

J Biol Chem. 2005 Sep 16;280(37):32379-88. Epub 2005 Jul 26.

9.

Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.

Zhuang Y, Faria TN, Chambon P, Gudas LJ.

Mol Cancer Res. 2003 Jun;1(8):619-30.

11.
12.

Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways.

Parrella E, Gianni' M, Cecconi V, Nigro E, Barzago MM, Rambaldi A, Rochette-Egly C, Terao M, Garattini E.

J Biol Chem. 2004 Oct 1;279(40):42026-40. Epub 2004 Jul 28.

13.

Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.

Wiener Z, Ontsouka EC, Jakob S, Torgler R, Falus A, Mueller C, Brunner T.

Exp Cell Res. 2004 Sep 10;299(1):227-35.

PMID:
15302589
14.

Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.

Ricaud S, Vernus B, Bonnieu A.

Exp Cell Res. 2005 Dec 10;311(2):192-204. Epub 2005 Oct 19.

PMID:
16236281
15.

Transcriptional regulation of urokinase receptor in high- (95D) and low-metastatic (95C) human lung cancer cells.

Li CY, Tan L, Zhang GJ, Li P, Tong C, Fan J, Zhu YS.

Acta Biochim Biophys Sin (Shanghai). 2004 Jun;36(6):405-11.

PMID:
15188055
16.

Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.

Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.

Int J Oncol. 2005 Oct;27(4):949-56.

PMID:
16142310
17.

Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.

Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK.

J Pathol. 2009 Aug;218(4):520-9. doi: 10.1002/path.2563.

PMID:
19431154
18.

In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group.

Um SJ, Han HS, Kwon YJ, Park SH, Bae TS, Rho YS, Sin HS.

Oncol Rep. 2004 Mar;11(3):719-26.

PMID:
14767528
19.

Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells.

Watabe M, Hishikawa K, Takayanagi A, Shimizu N, Nakaki T.

J Biol Chem. 2004 Feb 13;279(7):6017-26. Epub 2003 Nov 18.

20.

Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line.

Papi A, Bartolini G, Ammar K, Guerra F, Ferreri AM, Rocchi P, Orlandi M.

Oncol Rep. 2007 Oct;18(4):1015-21.

PMID:
17786368

Supplemental Content

Support Center